Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Willett

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Oncology (Williston Park, N.Y.)|January 16, 2004
Update on combined-modality treatment options for pancreatic cancerChristopher G Willett, Jeffrey W Clark
Cancer|January 2, 2009
Stereotactic radiotherapy for pancreatic cancer?Christopher H Crane, Christopher G Willett
Seminars in Radiation Oncology|June 8, 2011
Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapyBrian G Czito, Christopher G Willett
Current Treatment Options in Oncology|February 22, 2024
Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to ChooseChristopher G Willett, Scarlett Acklin-Wehnert
Journal of the National Cancer Institute|August 1, 2013
Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturationChristopher D Kontos, Christopher G Willett
Seminars in Radiation Oncology|June 8, 2011
Introduction: current controversies in rectal cancerBrian G Czito, Christopher G Willett
Current Oncology Reports|April 2, 2009
Current management of anal canal cancerBrian G Czito, Christopher G Willett
Gastrointestinal Cancer Research : GCR|May 23, 2009
In pursuit of progress: multimodality strategies will form the cornerstone of cure for esophageal cancerBrian G Czito, Christopher G Willett
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Is proton beam therapy better than standard radiation therapy? A paucity of practicality puts photons ahead of protonsJoseph K Salama, Christopher G Willett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Epigenetic markers in rectal cancerLei Xu, Brian G Czito, Christopher G Willett
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Oncology (Williston Park, N.Y.)|January 16, 2004
Update on combined-modality treatment options for pancreatic cancerChristopher G Willett, Jeffrey W Clark
Cancer|January 2, 2009
Stereotactic radiotherapy for pancreatic cancer?Christopher H Crane, Christopher G Willett
Seminars in Radiation Oncology|June 8, 2011
Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapyBrian G Czito, Christopher G Willett
Current Treatment Options in Oncology|February 22, 2024
Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to ChooseChristopher G Willett, Scarlett Acklin-Wehnert
Journal of the National Cancer Institute|August 1, 2013
Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturationChristopher D Kontos, Christopher G Willett
Seminars in Radiation Oncology|June 8, 2011
Introduction: current controversies in rectal cancerBrian G Czito, Christopher G Willett
Current Oncology Reports|April 2, 2009
Current management of anal canal cancerBrian G Czito, Christopher G Willett
Gastrointestinal Cancer Research : GCR|May 23, 2009
In pursuit of progress: multimodality strategies will form the cornerstone of cure for esophageal cancerBrian G Czito, Christopher G Willett
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Is proton beam therapy better than standard radiation therapy? A paucity of practicality puts photons ahead of protonsJoseph K Salama, Christopher G Willett
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Epigenetic markers in rectal cancerLei Xu, Brian G Czito, Christopher G Willett
Pageof 18